• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESMED LTD ACUCARE HFNC - MEDIUM; CANNULA, NASAL, OXYGEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESMED LTD ACUCARE HFNC - MEDIUM; CANNULA, NASAL, OXYGEN Back to Search Results
Model Number 23007
Device Problems Crack (1135); Gas/Air Leak (2946)
Patient Problem Low Oxygen Saturation (2477)
Event Date 07/03/2023
Event Type  Injury  
Manufacturer Narrative
The device was returned to resmed for an investigation.The investigation methods, results, and conclusion are not finalized at this stage.If more information becomes available, a supplemental report will be submitted.The acucare hfnc user guide provide the following warning:- ¿single patient reuse only.Maximum 7 days reuse in the hospital/clinical environment, 30 days reuse in the home environment if cleaning instructions are followed.¿ the acucare hfnc user guide provides the following warnings: - - ¿do not reuse.- do not use if components are damaged.- before connecting the nasal cannula, check for adequate gas flow, oxygen and temperature.- do not crush or stretch tubing.¿ resmed's risk analysis for this failure mode concludes that the risk is acceptable.Resmed reference#: (b)(6) h3 other text : device received; investigation pending.
 
Event Description
It was reported to resmed that a patient using an acucare high flow nasal cannula (hfnc) experienced desaturation of oxygen.It was reported that while travelling home in an ambulance from the hospital, the patient¿s oxygen saturation dropped to 80%, device displayed a high leak alarm and the hose of the hfnc was allegedly cracked and leaking.Patient returned to the hospital and subsequently expired.
 
Event Description
It was reported to resmed that a patient using an acucare high flow nasal cannula (hfnc) experienced desaturation of oxygen.It was reported that while travelling home in an ambulance from the hospital, the patient¿s oxygen saturation dropped to 80%, and the hose of the hfnc was allegedly cracked and leaking.Patient returned to the hospital and subsequently expired.
 
Manufacturer Narrative
The acucare hfnc was returned to resmed and an engineering investigation has been performed.Visual inspection confirmed a tear in the tubing film at the connection to the cannula.Based on the available information and resmed¿s internal investigation, physical abuse (tensile overloading) of the tubing film resulted in tearing of the device tubing.The acucare hfnc was within specification.There is insufficient evidence to suggest that the tear in the device had directly caused the reported patient death.There is no evidence to suggest a deviation in the manufacturing quality of the product.It was reported to resmed that the subject device was used in the hospital for approximately 2 weeks prior to the date of the incident.Acucare hfnc user guide states ¿the acucare hfnc is for single-patient use (maximum 7 days) in the hospital/clinical environment.¿ therefore, the cannula was used outside of its intended use of a maximum 7 days.Acucare hfnc user guide provides the following indications for use: ¿the acucare hfnc is intended for use in patients with acute respiratory failure or non-acute spontaneously breathing patients in the hospital/clinical environment, or for non-acute spontaneously breathing patients in the home.¿ acucare hfnc user guide provides the following warnings: ¿do not use if components are damaged.¿ ¿before connecting the nasal cannula, check for adequate gas flow, oxygen and temperature.¿ ¿do not crush or stretch tubing.¿ resmed's risk analysis for this failure mode concludes that the risk is acceptable.Resmed reference#: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUCARE HFNC - MEDIUM
Type of Device
CANNULA, NASAL, OXYGEN
Manufacturer (Section D)
RESMED LTD
1 elizabeth macarthur drive
bella vista
sydney, nsw 2153
AS  2153
Manufacturer (Section G)
RESMED PTY LTD
1 elizabeth macarthur drive
bella vista
sydney, nsw 2153
AS   2153
Manufacturer Contact
michelle hughes
1 elizabeth macarthur drive
bella vista
sydney, nsw 2153
AS   2153
MDR Report Key17928226
MDR Text Key325565342
Report Number3004604967-2023-00567
Device Sequence Number1
Product Code CAT
UDI-Device Identifier00619498230075
UDI-Public(01)00619498230075(10)1618934
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K133868
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number23007
Device Catalogue Number23007
Device Lot Number1618934
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date11/28/2023
Date Manufacturer Received11/28/2023
Was Device Evaluated by Manufacturer? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Death;
-
-